NIH PAR · NCI · R01
PAR-25-167: Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)
Reviewed by Dr. Meng ZhaoLast reviewed October 16, 2026Data refreshed October 16, 2026Editorial standards
Through this notice of funding opportunity (NOFO), the National Cancer Institute (NCI) invites applications for support of investigator-initiated clinical trials that have the potential to reduce the burden of cancer through improvements in early detection, screening, prevention and interception, healthcare delivery, quality of life, and/or survivorship related to cancer; with such attributes, the proposed studies should also have the potential to improve clinical practice and/or public health. Applications submitted to this NOFO must include studies that meet the National Institutes of Health (NIH) definition of a clinical trial (see NOT-OD-15-015 for details) and provide specific clinical…
- NOFO number
- PAR-25-167
- Type
- PAR
- Activity code
- R01
- Primary institute
- NCI · National Cancer Institute
- Clinical trials
- Required
- Posted
- Nov 12, 2024
- Opens
- Jan 5, 2025
- Expires
- Jan 8, 2027
PAR-25-167 due dates
No application due dates remain in the listed cycles. Dates marked * are NIH standard due dates. Check the related notices below for changes NIH made after posting.
| Application Due Date(s) | Renewal / Resubmission / Revision (as allowed) | AIDS - New/Renewal/Resubmission/Revision, as allowed | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
|---|---|---|---|---|---|
| February 05, 2025 | March 05, 2025 * | May 07, 2025 * | July 2025 | October 2025 | December 2025 |
| June 05, 2025 | July 05, 2025 * | September 07, 2025 * | November 2025 | January 2026 | April 2026 |
| October 05, 2025 | November 05, 2025 * | January 07, 2026 * | March 2026 | May 2026 | July 2026 |
| February 05, 2026 | March 05, 2026 * | May 07, 2026 * | July 2026 | October 2026 | December 2026 |
| June 05, 2026 | July 05, 2026 * | Not Applicable | November 2026 | January 2027 | April 2027 |
| October 05, 2026 | November 05, 2026 * | Not Applicable | March 2027 | May 2027 | July 2027 |
Projects funded under PAR-25-167
NIH RePORTER lists 71 projects funded under PAR-25-167 in FY2022–FY2026, with $48.3M in award dollars. Counts include each project's later non-competing years, which keep the original NOFO number.
Projects funded
71
Distinct projects, FY2022–FY2026
New awards
71
Type 1 (new project) award records
NIH funding
$48.3M
Award dollars under PAR-25-167, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 0 | 0 | $0 |
| FY2026 | 71 | 71 | $48.3M |
Institutions with the most funding
- Sloan-Kettering Inst Can Research$4.5M · 6 projects
- University of Tx MD Anderson Can Ctr$3.1M · 5 projects
- University of Rochester$2.2M · 1 project
- Massachusetts General Hospital$2.0M · 3 projects
- Rutgers Biomedical and Health Sciences$2.0M · 3 projects
- University of Michigan at Ann Arbor$1.9M · 3 projects
- Fred Hutchinson Cancer Center$1.7M · 2 projects
- University of Oklahoma Hlth Sciences Ctr$1.6M · 3 projects
Most recent new awards
- Assessing the Effectiveness and Implementation of group based Tobacco Treatment for older individuals undergoing lung cancer screening (opens NIH RePORTER)
Massachusetts General Hospital · 1R01CA303617-01A1 · NCI · Notice Sep 17, 2026
$713KR01
- Enhancing Cervical Cancer Screening through Integrated Care in Rural North Carolina (opens NIH RePORTER)
Univ of North Carolina Chapel Hill · 1R01CA317486-01 · NCI · Notice Sep 17, 2026
$607KR01
- Effectiveness of Medical and Environmental Interventions to Reduce Cystoscopy Discomfort (opens NIH RePORTER)
Veterans Education/Res/Assn/North/Ne · 1R01CA303719-01A1 · NCI · Notice Sep 17, 2026
$595KR01
- Randomized Trial of a Novel Intervention to Increase Endocrine Therapy Adherence among Depressed Breast Cancer Survivors (opens NIH RePORTER)
University of Colorado · 1R01CA303943-01A1 · NCI · Notice Sep 17, 2026
$653KR01
- Using real-time data capture to examine affective mechanisms as mediators of physical activity maintenance in interventions (opens NIH RePORTER)
University of Southern California · 1R01CA303696-01A1 · NCI · Notice Sep 17, 2026
$700KR01
- Playing it Safe in the Sun: A Parent-focused, Social Media-delivered Intervention to Improve Sun Safety for Young Children (opens NIH RePORTER)
Rutgers Biomedical and Health Sciences · 1R01CA311039-01 · NCI · Notice Sep 17, 2026
$674KR01
What its predecessor PAR-24-072 funded
PAR-25-167 reissues PAR-24-072. Its funding history is the best guide to who wins under this program: 37 projects and $52.9M in FY2022–FY2026.
Projects funded
37
Distinct projects, FY2022–FY2026
New awards
36
Type 1 (new project) award records
NIH funding
$52.9M
Award dollars under PAR-24-072, FY2022–FY2026
Funding by fiscal year
| Fiscal year | Award records | New awards | Funding |
|---|---|---|---|
| FY2022 | 0 | 0 | $0 |
| FY2023 | 0 | 0 | $0 |
| FY2024 | 0 | 0 | $0 |
| FY2025 | 37 | 34 | $29.5M |
| FY2026 | 37 | 2 | $23.4M |
Institutions with the most funding
- Massachusetts General Hospital$5.2M · 4 projects
- University of Miami Coral Gables$3.9M · 2 projects
- University of Virginia$3.4M · 1 project
- Case Western Reserve University$3.2M · 1 project
- Yale University$2.7M · 2 projects
- Univ of North Carolina Chapel Hill$2.5M · 2 projects
- Beth Israel Deaconess Medical Center$1.5M · 1 project
- Fred Hutchinson Cancer Center$1.5M · 1 project
Most recent new awards
- LIVe: Efficacy of Low Intensity Vibration Therapy to Reduce Symptoms of Peripheral Neuropathy and Preserve Functional Mobility After Chemotherapy for Cancer (opens NIH RePORTER)
Oregon Health & Science University · 1R01CA298345-01A1 · NCI · Notice Aug 13, 2026
$544KR01
- Multi-site Trial of a Brief Behavioral Intervention for Dyspnea in Patients with Advanced Lung Cancer (opens NIH RePORTER)
Massachusetts General Hospital · 1R01CA292902-01A1 · NCI · Notice Jul 7, 2026
$604KR01
- Evaluating the Impact of Accessible and Scalable Digital Interventions to Address Co-Occurring Insomnia and Depression in Breast Cancer Survivors Using an Adaptive Design (opens NIH RePORTER)
University of Virginia · 1R01CA295673-01A1 · NCI · Notice Sep 24, 2025
$3.4MR01
- Expanded Safety and Preliminary Efficacy of Adjuvant 5-Fluorouracil Following Thermal Ablation to Improve HPV Treatment Outcomes in Women with HIV in Africa (opens NIH RePORTER)
Univ of North Carolina Chapel Hill · 1R37CA306827-01 · NCI · Notice Sep 15, 2025
$606KR37
- Remotely-Delivered Cognitive Behavioral Stress Management Effects on Cancer-Accelerated Aging in Older, Distressed Breast Cancer Survivors (opens NIH RePORTER)
University of Miami Coral Gables · 1R01CA296071-01A1 · NCI · Notice Sep 12, 2025
$2.7MR01
- Thriving Beyond Treatment: A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship (opens NIH RePORTER)
Massachusetts General Hospital · 1R37CA303094-01 · NCI · Notice Sep 11, 2025
$818KR37
FY2026 closed on September 30, 2026, but NIH keeps posting that year's awards to RePORTER for several weeks. FY2026 figures reflect records available on October 16, 2026 and may rise slightly at the next refresh.
Participating institutes
2 NIH institutes and offices take applications under PAR-25-167. Contact the program officer at the institute that fits your research before applying.
- NCI · National Cancer Institute
- none
Related notices
Mar 31, 2025 · NOT-OD-24-084
This funding opportunity was updated to align with agency priorities. Carefully reread the full funding opportunity and make any needed adjustments to your application prior to submission.April 4, 2024 - Overview of Grant Application and Review Changes for Due Dates on or after January 25,…
Aug 31, 2022 · NOT-OD-22-198
Implementation Changes for Genomic Data Sharing Plans Included with Applications Due on or after January 25, 2023. See Notice NOT-OD-22-198.
Aug 5, 2022 · NOT-OD-22-189
Implementation Details for the NIH Data Management and Sharing Policy.
Notices of Special Interest (NOSIs)
NIH has attached 23 NOSIs to PAR-25-167; none are active now. A NOSI flags a topic an institute wants to fund through this NOFO.
Award terms
- Application types allowed
- NewRenewalResubmissionRevision The OER Glossary and the How to Apply Application Guide provide details on these application types. Only those application types listed here are allowed for this NOFO.
- Award budget
- Application budgets are not limited but need to reflect the actual needs of the proposed project.
- Project period
-  The maximum project period is 5 years. NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made from this NOFO.
- Funds available and number of awards
- The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
Summarized from the NOFO text; the full NOFO governs eligibility, budget, and review.
Related NOFOs
- Reissue of PAR-24-072.
- Companion NOFOs: PAR-25-081.
Other open NOFOs for R01
- PAR-25-336Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)NCI · next due Nov 16, 2026
- PAR-27-072Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)NCI · next due Feb 5, 2027
- PAR-25-337Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)NCI · next due Feb 5, 2027
- PAR-25-338Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Not Allowed)NCI · next due Feb 5, 2027
- PAR-25-243Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)NCI · next due Feb 5, 2027
- PA-25-172Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)NCI · next due Feb 5, 2027
About this page
GotGrant gathers the NOFO, its participation and change notices, and its NOSIs from the NIH Guide for Grants and Contracts, and counts funded projects from NIH RePORTER by the opportunity number each award was made under. Data refreshed October 16, 2026; the NIH Guide is the authoritative source. See our data methodology.